- Presentation
- Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)
- First posted
- Jul 18, 2023
- Updated at source
- Oct 14, 2026
View FDA presentations (10)
These notices concern specific presentations, not every product containing this ingredient. A current shortage and a planned discontinuation can be reported together. FDA availability notes do not confirm local pharmacy stock.
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)
In shortageFDA status: Current
Source availability: Available
Updated at source: Oct 14, 2026
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)
In shortageFDA status: Current
Source availability: Available
Updated at source: Oct 14, 2026
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)
In shortageFDA status: Current
Source availability: Available
Distributed by Teva
Updated at source: Sep 22, 2026
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)
In shortageFDA status: Current
Source availability: Available
Distributed by Teva
Updated at source: Sep 22, 2026
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)
Planned discontinuationFDA status: To Be Discontinued
Discontinuation of the manufacture of the drug
Posted by FDA: May 14, 2026
Updated at source: May 14, 2026
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
In shortageFDA status: Current
Source availability: Limited Availability
Reason: Discontinuation of the manufacture of the drug
Product will be available until discontinuation in January 2027
Updated at source: Sep 22, 2026
FDA status: To Be Discontinued
Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug
Posted by FDA: Aug 25, 2026
Updated at source: Aug 25, 2026
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)
In shortageFDA status: Current
Source availability: Available
Updated at source: Aug 27, 2026
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
In shortageFDA status: Current
Source availability: Available
Updated at source: Aug 27, 2026
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)
In shortageFDA status: Current
Source availability: Limited Availability
Reason: Delay in shipping of the drug
Estimated shortage duration: TBD
Updated at source: Sep 22, 2026
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)
In shortageFDA status: Current
Source availability: Limited Availability
Reason: Delay in shipping of the drug
Estimated shortage duration: TBD
Updated at source: Sep 22, 2026
Source: openFDA Drug Shortages (accessdata.fda.gov/scripts/drugshortages) · as of Nov 17, 2026
Full drug profile